Trials / Unknown
UnknownNCT00196209
Cardioversion vs. Catheter Ablation for Persistent Atrial Fibrillation
Randomized Study Comparing Cardioversion vs. Catheter Ablation in Patients With Persistent Atrial Fibrillation
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 130 (estimated)
- Sponsor
- Deutsches Herzzentrum Muenchen · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this randomized study is to evaluate the efficacy of two different approaches for conversion of persistent atrial fibrillation, the non-invasive one (external electrical cardioversion) and the invasive one (catheter ablation).
Detailed description
This randomized study compares two treatment strategies in patients with persistent atrial fibrillation: Cardioversion vs. catheter ablation. Cardioversion is a low risk standard treatment option for patients with persistent atrial fibrillation. However, mid- and long term efficacy (regarding the maintenance of sinus rhythm) is low. Catheter ablation is an invasive treatment which has been reported to result in up to 60-70% of patients in stable sinus rhythm. However, it is a potentially dangerous invasive procedure with potentially fatal complications. Comparison: External cardioversion vs. catheter ablation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | catheter ablation | catheter ablation to treat persistent atrial fibrillation |
| PROCEDURE | external electric cardioversion | external cardioversion and drug prophylaxis to treat persistent atrial fibrillation |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2009-06-01
- Completion
- 2009-12-01
- First posted
- 2005-09-20
- Last updated
- 2008-03-19
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00196209. Inclusion in this directory is not an endorsement.